Perspective on Pharma: Tackling AMR through sustainable antibiotic production

  24 October 2019

Antimicrobial resistance occurs naturally over time but the misuse and overuse are seen as the core problems accelerating the process of AMR. One area that is frequently overlooked is the environmental impact of antibiotics, including its production.

The production process of active pharmaceutical ingredients (APIs) and antibiotics naturally creates wastewater, which contains residual levels of antimicrobials. Sustainable production processes then see this wastewater treated, so that it is considered safe to release into the environment. However, this is not always the case and if not treated correctly or effectively, then antibiotics are released into the waterways, accelerating AMR through the environment.

Authors: Alba Tiley
Clean Environment  
Back


Display your AMR technology / product:

Global AMR Technologies Database

  • Preventive – Diagnostic – Antimicrobial technologies
  • Academia – Research Institutes – Start ups – SMEs – Multinationals
  • Early research <-> near market (max 5)
  • Global reach for funding / co-development / licensing
  • No costs (until year end 2019)

Festive Launch Database 19 Nov Symposium Dinner ‘Emerging Antimicrobials and Diagnostics in AMR 2019
Click to join the Symposium Dinner (to join the Symposium separate registration obligatory)

Display your technology >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!